Skip to main content
Back To Top Top Back To Top
This website publishes administrative rules on their effective dates, as designated by the adopting state agencies, colleges, and universities.

Rule 4729:5-5-02.1 | Provision of Ancillary Services in an Outpatient Pharmacy.


(A) As used in this rule, "ancillary services" are services performed by pharmacy personnel that are performed in addition to, or outside of, the dispensation of dangerous drugs.

(1) Ancillary services include, but are not limited to, immunizations, drug administration, medication therapy management, disease state management, and refill reminders.

(2) Ancillary services do not include services provided by an outpatient pharmacy to patients upon discharge from an institutional facility as defined in Chapter 4729:5-9 of the Administrative Code.

(B) In accordance with division (D) of section 4729.55 of the Revised Code, an outpatient pharmacy licensed as a terminal distributor of dangerous drugs shall not establish any quotas relating to the provision of ancillary services.

(1) For purposes of this rule, "quota" means a fixed number or formula related to the duties of pharmacy personnel, against which the pharmacy or its agent measures or evaluates the number of times either an individual performs tasks or provides services while on duty.

(2) For purposes of this rule, "quota" does not mean any of the following:

(a) A measurement of the revenue earned by a pharmacy not calculated in relation to, or measured by, the tasks performed, or services provided by pharmacy personnel.

(b) Any evaluation or measurement of the competence, performance, or quality of care provided to patients of pharmacy personnel if the evaluation does not use quotas.

(c) Any performance metric required by state or federal regulators.

(C) This rule does not apply to outpatient pharmacies that are not open to the public (e.g., closed door pharmacies).

Last updated May 1, 2024 at 8:40 AM

Supplemental Information

Authorized By: 4729.26
Amplifies: 4729.54, 4729.55
Five Year Review Date: 5/1/2029